Home › Funds › GMO › GMO Emerging Markets Fund
Fund family: GMO · Filed by GMO TRUST (CIK 772129) · SEC series S000004911
Share classes and tickers: GEMEX (C000213363), GEMMX (C000013272), GEMNX (C000213362), GEMVX (C000013271), GMEFX (C000013270), GMEMX (C000013268), GMOEX (C000013269)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 2,266 with, 4 against, 36 abstentions (not counted as with management); 116 items carried no recommendation. Shareholder proposals: 13 FOR, 8 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as GMO’s manager page (51,210 ballot items across 26 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | GMO | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 78.2% | 1,544 | 91.3% | 40,970 |
| Backed environmental and social shareholder proposals at US companies | n/a | 0 | 10.3% | 369 |
Each ballot item this fund voted is set against the votes of the other GMO funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted the same way as most GMO funds on all 1,490 items where a comparison was possible.
| Proposal type | Items | Against management |
|---|---|---|
| Corporate Governance | 808 | 0 |
| Director Elections | 790 | 4 |
| Capital Structure | 376 | 0 |
| Compensation | 208 | 0 |
| Audit-related | 160 | 0 |
| Other | 40 | 0 |
| Extraordinary Transactions | 29 | 0 |
| Other Social Issues | 6 | 0 |
| Shareholder Rights and Defenses | 4 | 0 |
| Environment or Climate | 1 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| CEMEX SAB de CV | March 26, 2026 | $6M | 35 | 0 |
| Alibaba Group Holding Limited | September 25, 2025 | $5M | 7 | 0 |
| KB Financial Group, Inc. | March 26, 2026 | $176,805 | 11 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| September 9, 2025 | GMO U.S. Treasury Fund | Election of Trustees: Paul Braverman | For | Against |
| September 9, 2025 | GMO U.S. Treasury Fund | Election of Trustees: Peter Tufano | For | Against |
2,422 ballot items at 252 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, GMO Emerging Markets Fund (GEMEX) voted at 252 shareholder meetings of 209 companies, on 2,422 ballot items in all. Where management made a recommendation, the fund followed it on 98.3% of the items and voted against it 4 times. Its most frequent area of disagreement was director elections (4 of its votes against management). It voted on 21 shareholder proposals. It voted FOR the board's own proposals less often than GMO's funds as a whole (78.2% against 91.3%). It voted the same way as most GMO funds on every item where a comparison was possible.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of GMO’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.